Sign in

CIK 0001035354

  • Non-accelerated filer
  • Smaller reporting company

Eloxx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841368850
Phone
+1 781-577-5300
Business address
P.O. BOX 274, ARLINGTON, MA, 02476
Former names
Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
  1. 4 Open-market buy Director bought 200,000 shares at $9.00 ($1,800,000)
  2. 4 Open-market buy Director bought 200,000 shares at $9.00 ($1,800,000)
  3. 4 Open-market buy 10% owner bought 200,000 shares at $9.00 ($1,800,000)
  4. 4/A Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 10,467 shares (to pay taxes)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 83,038 shares (to pay taxes)

Page 7 of 29 · 574 filings